Tessa Therapeutics Ltd. is on the creditors' voluntary liquidation route under the IRDA 2018. Most recent notice: annual meeting in liquidation (11 Sep 2026).
The directors concluded that the company cannot continue its business because of its liabilities. Creditors confirm the liquidator at their meeting and share in whatever is recovered after costs and preferential debts.
Route in one line:Directors accept the company cannot pay its way; creditors confirm the liquidator at a section 166 meeting.How this route works →
Gazette history
Notices published
Every insolvency advertisement we matched to this UEN, oldest first, with a link to the gazetted PDF. The last entry is the usual next step.
11 Sep 2026
Annual meeting in liquidation
The liquidation has been running for more than a year, so the liquidator must convene an annual meeting to account for the conduct of the winding up during the preceding… Gazette PDF ↗
next
Continuing
The winding up continues; the next step is a dividend or the final meeting.
Registered office
Address and sources
Region
Central Region
12 MARINA VIEW #15-01 ASIA SQUARE TOWER 2 Singapore 018961
Tessa Therapeutics Ltd. is registered with ACRA under UEN 201120185N. Entity type: public company limited by shares. It was incorporated on 26 August 2011, about 15 years before its first insolvency notice. ACRA entity status at our last check: In Liquidation - Creditors voluntary winding up. The office-holder named in the notices is from KPMG Services. The Gazette notice is the authoritative record; the summary above is compiled from it.
Compiled from public Gazette notices and ACRA open data. Not an official extract; check the gazetted notice before relying on it.